₹ 72.95
1.84 (2.59%)
BSE
C
Concord Drugs
₹ 72.95
BSE
CONCORD Financials Summary (Consolidated)
Concord Drugs revenue decreased 44.85% quarter-on-quarter to ₹21 Cr in Jun 2026, while net profit increased 120.00% quarter-on-quarter to ₹1 Cr. Compared to the same quarter last year, revenue is up 53.68% and net profit is up 1,000.00%. EPS for the quarter stood at ₹0.85, increased from ₹0.47 in the previous quarter and up from ₹0.12 a year ago.
Concord Drugs Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of CONCORD Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
CONCORD Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






